Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Recruiting · NCT05616793 · Registry updated 2026-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients | Eye Diseases, Hereditary, Leber congenital amaurosis 5, eye disorder, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2026-02-19 | NCT05616793 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Opus Genetics, Inc | 3 |
| University of Pennsylvania | 502 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Retina Foundation of the Southwest | Dallas | United States | 38 |
| University of Pennsylvania Perelman School of Medicine | Philadelphia | United States | 10 |